Skip to main content
Pre-diabetesExercise and fitnessMetabolic

What this study is

Pre-diabetes (Pre-D) is a precursor to type 2 diabetes (T2D) and characterized by increased exercise fatigability of lower limb muscles, that can impede exercise performance. The cause for the increased fatigability in people with Pre-D is not known. Given the profound vascular disease present in people who have had uncontrolled diabetes for several years, we will determine whether dynamic, fatiguing contractions of the lower limb muscles in people with Pre-D are limited by vascular dysfunction at multiple levels along the vascular tree including the artery, arteriole, and/or capillary. This clinical trial involves a novel exercise training regime involving blood flow restriction to the exercising limb will be used as a probe to further understand the vascular mechanisms for increased fatigability in people with Pre-D and T2D. The long-term goal is to better understand what limits exercise and functional performance in people with diabetes to help develop targeted, more effective exercise programs.

What's being tested

  • Control Exercise

    Intervention · OTHER

    Each participant will attend 3 sessions per week for 8 weeks. Participants will perform low-load knee extension resistance training (20% of 1-RM) without blood flow restriction on the designated leg for 4 sets of contractions with 15 contractions per set of contractions with a 30 second rest between each set of contractions.

  • Blood Flow Restriction Exercise

    Intervention · OTHER

    Each participant will attend 3 sessions per week for 8 weeks. Participants will perform low-load knee extension resistance training (20% of 1-RM) with blood flow restriction on the designated leg for 4 sets of contractions with 15 contractions per set of contractions with a 30 second rest between each set of contractions.

Study details

Official title
Mechanisms of Fatigability and the Protective Effects of Exercise in People With Diabetes
Sponsor
University of Michigan
Conditions
Pre-diabetes · Type 2 Diabetes
Enrolling
80 people
Starts
2022-09-01
Est. completion
2027-08-31
Design
Open-label, randomized, parallel groups
Record
View on ClinicalTrials.gov ↗